I’m Doing an IPO and My D&O Insurance is Expensive

Update: 2018-10-01

Description

Why D&O Insurance is expensive for life science companies and how the stage your company is in impacts pricing.

Comments

In Channel

Where does the market go from here? Will retail investors sell?

2018-11-2109:21

What’s the deal with GE?

2018-11-1608:34

We changed our name and Amazon announced their new locations!

2018-11-1410:31

A $500 Million Biotech IPO. Amarin Data

2018-11-1209:04

Herd Mentality. Why D&O benchmarking is a sales ploy. What to use to make a more informed decision.

2018-11-0909:14

Why cost should only be one consideration

2018-11-0605:24

S&P Companies not as negative; Gene Therapy manufacturing is stretched thin

2018-11-0507:21

Lessons from Halloween when your kids have peanut allergies

2018-11-0108:56

Swimming and the Dow Jones

2018-10-2905:09

President’s Drug Pricing Speech and New CA Sexual Harassment Law

2018-10-2508:49

M&A Activity - Will Market Forces Play a Role?

2018-10-2403:28

Episode 36 - Concept or Concrete?

2018-10-1902:09

Episode 35 - McDermott Will & Emery Dealmaking Symposium Recap

2018-10-1809:57

Episode 34 - DeviceTalks Recap

2018-10-1707:39

Episode 33 - Chinese Espionage and Cyber Coverage

2018-10-0406:17

Episode 32 - Can the Biotech IPO Market Sustain Itself?

2018-10-0305:35

I’m Doing an IPO and My D&O Insurance is Expensive

2018-10-0108:03

FDA Condemns Undamaged Product - Insurance Should Have Paid

2018-09-2505:16

Episode 29 - MD Bio-Tech Conference Recap

2018-09-2111:28

Episode 28 - NJTC CFO Forum Recap

2018-09-1910:20

00:00

I’m Doing an IPO and My D&O Insurance is Expensive

Life Sciences Rush Hour - Inve

#box-pro-ellipsis-17614767647654{-webkit-line-clamp:2;}I’m Doing an IPO and My D&O Insurance is Expensive

I’m Doing an IPO and My D&O Insurance is Expensive

Life Sciences Rush Hour - Inve

I’m Doing an IPO and My D&O Insurance is Expensive